Company intelligence
Inocras Inc.
Whole genome power. Whole patient impact
About Inocras Inc.
Inocras is a bioinformatics-led company redefining precision health through whole genome data and proprietary analytics. Our oncology and rare disease platforms integrate comprehensive whole genome data with advanced automation to deliver curated and actionable insights at scale. These capabilities deliver curated, actionable insights that accelerate discovery and diagnostics to improve patient care, bringing a real-world impact. We operate a CLIA/CAP-certified laboratory and partners with leading hospitals, pharmaceutical companies, and research institutions worldwide.
Verified activity
Signals from Inocras Inc.
3 published signals
Presence & Recognition
Inocras Inc. hosted the Inocras Lung Cancer Symposium on Saturday, September 12, 2026, at the Textile Center in Seoul, South Korea.
Reported by Inocras Inc.
Presence & Recognition
Inocras Inc. is attending the IASLC 2026 World Conference on Lung Cancer in Seoul.
Reported by Inocras Inc.
Research & Knowledge
Inocras Inc. published a new study in npj Precision Oncology showing that Whole Genomic Profiling (WGS) can uncover clinically relevant genomic alterations in metastatic prostate cancer compared to targeted panels.
Reported by Inocras Inc.